| Literature DB >> 31778436 |
J Taradaj1,2, K Rajfur3, J Rajfur3, K Ptaszkowski4, L Ptaszkowska3, M Sopel5, J Rosińczuk5, R Dymarek5.
Abstract
The management of nonspecific lumbar pain (NSLP) using laser irradiation remains controversial. A systematic review of recently published studies indicates that the effects of laser therapy are commonly assessed using only imperfect methods in terms of measurement error. The main objective of this study was to assess static postural stability using an objective tool in patients with chronic NSLP after laser irradiation at different doses and wavelengths. In total, 68 patients were included in the laser sessions and were randomly assigned into four groups: high-intensity laser therapy at 1064 nm and 60 J/cm2 for 10 min (HILT), sham (HILT placebo), low-level laser therapy at 785 nm and 8 J/cm2 for 8 min (LLLT), and sham (LLLT placebo). In addition, all patients were supplemented with physical exercises (standard stabilization training). To assess postural stability, a double-plate stabilometric platform was used. All measurements were performed pre- and post-laser sessions (three weeks) and at follow-up time points (one and three months). Laser procedures led to more balanced posture stability in patients, although these positive changes were significant mainly for short-term observation (after 4-week therapy). In the follow-up analysis, the parameters were gradually impaired. Kruskal-Wallis analysis of variance (ANOVA) for independent variables did not show any difference between the studied groups. Low- and high-intensity laser therapy does not lead to a significant improvement in postural sway in patients with NSLP compared with standard stabilization training based on short- and long-term observations.Entities:
Mesh:
Year: 2019 PMID: 31778436 PMCID: PMC6886387 DOI: 10.1590/1414-431X20198474
Source DB: PubMed Journal: Braz J Med Biol Res ISSN: 0100-879X Impact factor: 2.590
Demographic characteristics of participants in the study.
| Character | Group | N | Mean | Median | Min | Max | Q25 | Q75 | SD | P value |
|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | HILT | 18 | 44.67 | 44.00 | 29.00 | 58.00 | 41.00 | 48.00 | 4.96 | 0.8436 |
| HILT (p) | 17 | 44.24 | 45.00 | 26.00 | 51.00 | 41.00 | 47.00 | 4.34 | ||
| LLLT | 16 | 45.19 | 45.50 | 29.00 | 53.00 | 42.00 | 47.50 | 4.17 | ||
| LLLT (p) | 17 | 45.76 | 52.00 | 22.00 | 76.00 | 36.00 | 56.00 | 15.04 | ||
| Height (cm) | HILT | 18 | 168.7 | 169.5 | 162.0 | 175.0 | 164.0 | 172.0 | 4.26 | 0.7176 |
| HILT (p) | 17 | 169.4 | 172.0 | 158.0 | 181.0 | 159.0 | 175.0 | 7.98 | ||
| LLLT | 16 | 168.9 | 168.0 | 156.0 | 176.0 | 168.0 | 172.0 | 4.57 | ||
| LLLT (p) | 17 | 169.8 | 170.0 | 164.0 | 177.0 | 168.0 | 171.0 | 2.96 | ||
| Body weight (kg) | HILT | 18 | 74.17 | 75.00 | 57.00 | 90.00 | 65.00 | 83.00 | 11.41 | 0.9674 |
| HILT (p) | 17 | 73.94 | 75.00 | 54.00 | 92.00 | 65.00 | 84.00 | 11.81 | ||
| LLLT | 16 | 75.38 | 75.00 | 59.00 | 92.00 | 62.00 | 90.00 | 12.99 | ||
| LLLT (p) | 17 | 76.06 | 78.00 | 55.00 | 87.00 | 74.00 | 82.00 | 8.89 | ||
| BMI (kg/m2) | HILT | 18 | 25.96 | 26.64 | 21.19 | 31.14 | 22.76 | 28.39 | 3.11 | 0.9782 |
| HILT (p) | 17 | 25.69 | 25.35 | 21.36 | 30.46 | 22.58 | 28.44 | 3.25 | ||
| LLLT | 16 | 26.42 | 26.25 | 19.05 | 31.89 | 21.97 | 30.42 | 4.31 | ||
| LLLT (p) | 17 | 26.36 | 27.04 | 18.59 | 28.38 | 26.93 | 27.77 | 2.86 | ||
| Duration of disease (months) | HILT | 18 | 55.89 | 57.00 | 46.00 | 64.00 | 51.00 | 60.00 | 5.97 | 0.9610 |
| HILT (p) | 17 | 55.41 | 56.00 | 46.00 | 64.00 | 52.00 | 60.00 | 5.96 | ||
| LLLT | 16 | 54.56 | 56.00 | 36.00 | 68.00 | 48.50 | 61.50 | 8.88 | ||
| LLLT (p) | 17 | 56.47 | 58.00 | 47.00 | 65.00 | 52.00 | 60.00 | 5.68 | ||
| Pain (VAS) | HILT | 18 | 7.22 | 8.00 | 4.00 | 10.00 | 5.00 | 9.00 | 1.96 | 0.0931 |
| HILT (p) | 17 | 7.59 | 8.00 | 5.00 | 9.00 | 7.00 | 9.00 | 1.42 | ||
| LLLT | 16 | 8.50 | 9.00 | 5.00 | 10.00 | 8.00 | 9.50 | 1.55 | ||
| LLLT (p) | 17 | 7.18 | 7.00 | 5.00 | 10.00 | 6.00 | 8.00 | 1.67 | ||
| Pain (LATQ) | HILT | 18 | 9.22 | 8.00 | 5.00 | 15.00 | 7.00 | 11.00 | 3.08 | 0.1047 |
| HILT (p) | 17 | 8.65 | 9.00 | 4.00 | 13.00 | 6.00 | 12.00 | 3.24 | ||
| LLLT | 16 | 7.75 | 8.00 | 4.00 | 12.00 | 6.00 | 9.00 | 2.32 | ||
| LLLT (p) | 17 | 6.94 | 6.00 | 4.00 | 12.00 | 5.00 | 9.00 | 2.66 | ||
| Schober test (cm) | HILT | 18 | 3.00 | 3.00 | 2.00 | 4.00 | 3.00 | 3.00 | 0.59 | 0.2889 |
| HILT (p) | 17 | 2.71 | 2.50 | 2.00 | 4.00 | 2.00 | 3.00 | 0.64 | ||
| LLLT | 16 | 3.19 | 3.00 | 2.00 | 4.00 | 3.00 | 3.50 | 0.54 | ||
| LLLT (p) | 17 | 4.12 | 4.00 | 3.00 | 5.00 | 3.00 | 5.00 | 0.86 | ||
| Laseque test - left extremity (o) | HILT | 18 | 60.83 | 60.00 | 25.00 | 85.00 | 55.00 | 75.00 | 17.84 | 0.2467 |
| HILT (p) | 17 | 39.71 | 35.00 | 25.00 | 60.00 | 30.00 | 50.00 | 11.38 | ||
| LLLT | 16 | 54.69 | 57.50 | 30.00 | 80.00 | 30.00 | 70.00 | 18.84 | ||
| LLLT (p) | 17 | 56.18 | 55.00 | 35.00 | 75.00 | 50.00 | 65.00 | 13.17 | ||
| Laseque test - right extremity (o) | HILT | 18 | 61.67 | 60.00 | 40.00 | 80.00 | 55.00 | 70.00 | 12.72 | 0.2045 |
| HILT (p) | 17 | 38.24 | 30.00 | 30.00 | 60.00 | 30.00 | 45.00 | 12.11 | ||
| LLLT | 16 | 52.81 | 57.50 | 25.00 | 75.00 | 30.00 | 70.00 | 18.71 | ||
| LLLT (p) | 17 | 58.53 | 65.00 | 30.00 | 75.00 | 50.00 | 65.00 | 13.32 |
Min: minimum value; Max: maximum value; Q25: lower quartile; Q75: upper quartile; SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group. BMI: body mass index; VAS: visual analog scale; LATQ: Laitinen questionnaire. Statistical analysis was done with ANOVA.
Figure 1.CONSORT flowchart of patients' recruitment and study flow. HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.
Figure 2.Patient during the high-intensity laser therapy application.
Figure 3.Patient during the low-level laser therapy application.
Figure 4.Patient during the static postural stability measurement.
Sway path results (mm).
| Before therapy mean (SD) | After therapy mean (SD) | 1-month follow-up mean (SD) | 3-months follow-up mean (SD) | *P value | |
|---|---|---|---|---|---|
| Open eyes | |||||
| HILT | 197.83 (35.49) | 123.44 (42.22) | 156.06 (31.78) | 193.83 (42.60) | 0.0281 |
| HILT (p) | 202.56 (42.89) | 130.07 (50.33) | 163.78 (42.31) | 196.68 (50.12) | 0.0220 |
| LLLT | 193.77 (34.88) | 128.44 (41.03) | 157.01 (45.78) | 185.77 (48.90) | 0.0288 |
| LLLT (p) | 198.49 (31.33) | 125.56 (40.12) | 160.11 (40.21) | 193.70 (51.34) | 0.0250 |
| **P value | 0.4550 | 0.5455 | 0.4980 | 0.5380 | |
| Closed eyes | |||||
| HILT | 282.50 (85.03) | 206.62 (68.92) | 259.67 (73.73) | 274.44 (114.70) | 0.0310 |
| HILT (p) | 275.34 (90.21) | 198.45 (70.27) | 256.89 (80.12) | 272.89 (120.78) | 0.0278 |
| LLLT | 281.56 (84.32) | 202.89 (65.89) | 260.01 (70.27) | 274.21 (103.72) | 0.0312 |
| LLLT (p) | 279.21 (83.88) | 200.78 (67.90) | 262.80 (80.11) | 280. 11 (130.34) | 0.0316 |
| **P value | 0.4670 | 0.4878 | 0.5110 | 0.5122 |
*Friedman ANOVA, level of significance (before vs after vs 1-month follow-up vs 3-months follow-up). **Kruskal-Wallis ANOVA, level of significance (HILT vs HILT (p) vs LLLT vs LLLT (p) group). SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.
Sway path along the Y-axis results (mm).
| Before therapy mean (SD) | After therapy mean (SD) | 1-month follow-up mean (SD) | 3-months follow-up mean (SD) | *P value | |
|---|---|---|---|---|---|
| Open eyes | |||||
| HILT | 140.56 (27.09) | 109.33 (36.39) | 116.65 (42.11) | 133.02 (43.08) | 0.0410 |
| HILT (p) | 142.01 (23.34) | 112.76 (39.89) | 120.80 (43.29) | 140.08 (45.88) | 0.0422 |
| LLLT | 146.03 (27.83) | 115.01 (38.33) | 122.02 (40.22) | 140.11 (50.01) | 0.0422 |
| LLLT (p) | 139.44 (20.86) | 108.99 (38.45) | 115.88 (40.71) | 135.02 (50.44) | 0.0420 |
| **P value | 0.5788 | 0.2880 | 0.4060 | 0.5010 | |
| Closed eyes | |||||
| HILT | 232.61 (84.43) | 189.77 (89.67) | 197.22 (92.01) | 227.08 (92.76) | 0.0466 |
| HILT (p) | 235.11 (84.22) | 192.18 (90.78) | 199.03 (92.11) | 228.06 (93.89) | 0.0468 |
| LLLT | 238.02 (90.11) | 195.07 (92.06) | 201.45 (92.77) | 227.99 (98.05) | 0.0466 |
| LLLT (p) | 231.10 (80.12) | 183.39 (80.78) | 194.02 (90.70) | 226.20 (100.04) | 0.0476 |
| **P value | 0.7677 | 0.4180 | 0.5166 | 0.7890 |
*Friedman ANOVA, level of significance (before vs after vs 1-month follow-up vs 3-months follow-up). **Kruskal-Wallis ANOVA, level of significance (HILT vs HILT (p) vs LLLT vs LLLT (p) group). SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.
Sway path along the X-axis results (mm).
| Before therapy mean (SD) | After therapy mean (SD) | 1-month follow-up mean (SD) | 3-months follow-up mean (SD) | *P value | |
|---|---|---|---|---|---|
| Open eyes | |||||
| HILT | 100.01 (22.19) | 79.07 (23.33) | 86.55 (24.02) | 97.99 (24.88) | 0.0355 |
| HILT (p) | 99.12 (20.02) | 75.03 (22.88) | 84.88 (25.02) | 93.89 (25.12) | 0.0300 |
| LLLT | 101.06 (21.86) | 78.67 (23.04) | 87.01 (24.76) | 99.10 (25.25) | 0.0350 |
| LLLT (p) | 99.88 (20.13) | 78.77 (22.03) | 88.80 (23.11) | 97.22 (24.33) | 0.0350 |
| **P value | 0.7710 | 0.6890 | 0.6678 | 0.7010 | |
| Closed eyes | |||||
| HILT | 116.22 (24.10) | 90.57 (24.33) | 100.01 (24.37) | 111.23 (25.06) | 0.0450 |
| HILT (p) | 112.56 (22.11) | 89.08 (23.04) | 100.44 (23.21) | 108.02 (24.88) | 0.0422 |
| LLLT | 119.66 (20.10) | 93.30 (22.02) | 94.99 (22.79) | 107.03 (24.05) | 0.0447 |
| LLLT (p) | 112.19 (21.78) | 90.80 (23.01) | 97.89 (23.01) | 110.03 (23.05) | 0.0451 |
| **P value | 0.7102 | 0.7450 | 0.4569 | 0.6200 |
*Friedman ANOVA, level of significance (before vs after vs 1-month follow-up vs 3-months follow-up). **Kruskal-Wallis ANOVA, level of significance (HILT vs HILT (p) vs LLLT vs LLLT (p) group). SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.
Mean velocity results (mm/s).
| Before therapy mean (SD) | After therapy mean (SD) | 1-month follow-up mean (SD) | 3-months follow-up mean (SD) | *P value | |
|---|---|---|---|---|---|
| Open eyes | |||||
| HILT | 6.58 (1.18) | 4.02 (1.22) | 5.12 (1.24) | 5.97 (1.43) | 0.0368 |
| HILT (p) | 6.50 (1.23) | 4.01 (1.23) | 5.03 (1.20) | 5.89 (1.25) | 0.0370 |
| LLLT | 6.62 (1.37) | 4.19 (1.35) | 5.21 (1.34) | 6.01 (1.45) | 0.0402 |
| LLLT (p) | 6.64 (1.50) | 4.16 (1.32) | 5.16 (1.34) | 5.92 (1.34) | 0.0370 |
| **P value | 0.5780 | 0.4889 | 0.4880 | 0.5330 | |
| Closed eyes | |||||
| HILT | 9.42 (2.83) | 6.06 (3.01) | 7.56 (3.11) | 8.04 (3.55) | 0.0318 |
| HILT (p) | 9.31 (2.08) | 5.89 (3.12) | 7.50 (3.30) | 8.34 (3.67) | 0.0318 |
| LLLT | 10.02 (3.11) | 6.57 (4.11) | 7.74 (3.12) | 8.40 (3.44) | 0.0278 |
| LLLT (p) | 10.05 (3.21) | 6.70 (4.12) | 7.82 (4.30) | 8.42 (3.67) | 0.0276 |
| **P value | 0.1138 | 0.1160 | 0.6110 | 0.7205 |
*Friedman ANOVA, level of significance (before vs after vs 1-month follow-up vs 3-months follow-up). **Kruskal-Wallis ANOVA, level of significance (HILT vs HILT (p) vs LLLT vs LLLT (p) group). SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.
Mean frequency results (Hz).
| Before therapy mean (SD) | After therapy mean (SD) | 1-month follow-up mean (SD) | 3-months follow-up mean (SD) | *P value | |
|---|---|---|---|---|---|
| Open eyes | |||||
| HILT | 0.39 (0.18) | 0.36 (0.22) | 0.36 (0.23) | 0.37 (0.23) | 0.8618 |
| HILT (p) | 0.35 (0.21) | 0.35 (0.24) | 0.36 (0.23) | 0.36 (0.25) | 0.9022 |
| LLLT | 0.36 (0.21) | 0.35 (0.25) | 0.36 (0.25) | 0.37 (0.25) | 0.9112 |
| LLLT (p) | 0.36 (0.18) | 0.34 (0.20) | 0.37 (0.22) | 0.36 (0.23) | 0.9170 |
| **P value | 0.7700 | 0.7890 | 0.7820 | 0.7330 | |
| Closed eyes | |||||
| HILT | 0.48 (0.20) | 0.45 (0.25) | 0.48 (0.31) | 0.50 (0.31) | 0.7180 |
| HILT (p) | 0.51 (0.24) | 0.47 (0.30) | 0.47 (0.30) | 0.49 (0.31) | 0.7060 |
| LLLT | 0.51 (0.25) | 0.48 (0.30) | 0.49 (0.29) | 0.50 (0.30) | 0.7205 |
| LLLT (p) | 0.50 (0.21) | 0.48 (0.31) | 0.50 (0.30) | 0.51 (0.32) | 0.7200 |
| **P value | 0.6890 | 0.6678 | 0.6780 | 0.7005 |
*Friedman ANOVA, level of significance (before vs after vs 1-month follow-up vs 3-months follow-up). **Kruskal-Wallis ANOVA, level of significance (HILT vs HILT (p) vs LLLT vs LLLT (p) group). SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.
Sway area results (mm2).
| Before therapy mean (SD) | After therapy mean (SD) | 1-month follow-up mean (SD) | 3-months follow-up mean (SD) | *P value | |
|---|---|---|---|---|---|
| Open eyes | |||||
| HILT | 180.50 (87.73) | 110.21 (70.21) | 130.93 (72.03) | 171.32 (73.10) | 0.0338 |
| HILT (p) | 178.11 (86.32) | 108.08 (69.44) | 127.04 (70.22) | 170.30 (71.31) | 0.0350 |
| LLLT | 178.59 (89.21) | 109.11 (70.25) | 125.45 (72.25) | 165.09 (73.05) | 0.0352 |
| LLLT (p) | 179.28 (86.88) | 109.02 (67.89) | 127.08 (70.04) | 168.47 (70.99) | 0.0289 |
| **P value | 0.7702 | 0.8228 | 0.6112 | 0.6102 | |
| Closed eyes | |||||
| HILT | 374.44 (213.15) | 312.62 (215.11) | 355.12 (215.24) | 362.08 (216.05) | 0.0387 |
| HILT (p) | 370.55 (210.12) | 310.72 (211.32) | 349.29 (213.13) | 359.88 (214.62) | 0.0390 |
| LLLT | 368.88 (207.03) | 309.66 (210.13) | 351.26 (210.49) | 360.36 (212.03) | 0.0392 |
| LLLT (p) | 371.03 (210.12) | 310.22 (210.89) | 349.98 (211.23) | 361.01 (112.43) | 0.0380 |
| **P value | 0.8442 | 0.8878 | 0.8889 | 0.8980 |
*Friedman ANOVA, level of significance (before vs after vs 1-month follow-up vs 3-months follow-up). **Kruskal-Wallis ANOVA, level of significance (HILT vs HILT (p) vs LLLT vs LLLT (p) group). SD: standard deviation; HILT: high-intensity laser therapy group; HILT (p): high-intensity laser therapy sham group; LLLT: low-level laser therapy group; LLLT (p): low-level laser therapy sham group.